An herbal formula, CGX, exerts hepatotherapeutic effects on dimethylnitrosamine-induced chronic liver injury model in rats

Table 1 Hematological analysis

Groups	Naive	DMN 4wk	Control	CGX 100	CGX 200
Erythrocyte (106/μL)	8.0 ± 0.3	7.1 ± 0.9	7.5 ± 1.5	8.4 ± 0.4	8.2 ± 0.5
Hemoglobin (g/dL)	15.4 ± 0.8	13.5 ± 1.3	14.0 ± 2.3	14.9 ± 0.6	14.8 ± 0.4
Hematocrit (%)	41.9 ± 1.4	35.2 ± 2.9	40.0 ± 6.1	40.9 ± 1.8	41.2 ± 2.6
Platelets (103/μL)	596 ± 459	449 ± 170	848 ± 265	795 ± 357	502 ± 305
Leukocytes (103/μL)	4.8 ± 1.2	4.9 ± 2.0	4.2 ± 1.8	2.6 ± 1.0	3.3 ± 1.2
Neutrophil (%)	17.1 ± 3.7	50.5 ± 7.1	39.7 ± 18.5b	32.2 ± 9.1	34.7 ± 20.2
Lymphocyte (%)	79.2 ± 3.7	44.2 ± 6.0	53.3 ± 18.4b	63.9 ± 10.1	61.1 ± 19.2
Monocytes (%)	3.6 ± 0.8	4.7 ± 1.7	6.6 ± 1.5c	3.6 ± 2.0a	3.8 ± 1.3a
Eosinophil (%)	0.1 ± 0.1	0.4 ± 0.3	0.4 ± 0.4	0.3 ± 0.2	0.3 ± 0.3
Basophil (%)	0.0 ± 0.0	0.2 ± 0.1	0.1 ± 0.2	0.1 ± 0.0	0.1 ± 0.2

After just 4-wk DMN treatment (DMN 4 wk), and after 6-wk full experiment for or control group including naïve group, complete blood count analysis was performed using EDTA-mixed blood.

^aP < 0.05 vs control group;

^cP < 0.05,

^bP < 0.01 vs naive group.